首鋼股份(000959.SZ):發行股份購買資產並募集配套資金事項獲得批覆
格隆匯12月17日丨首鋼股份(000959.SZ)公佈,根據北京市人民政府國有資產監督管理委員會《市國資委授權放權清單》授權,首鋼集團有限公司於2021年12月17日對公司本次發行股份購買資產並募集配套資金暨關聯交易事項出具《首鋼集團有限公司關於北京首鋼股份有限公司發行股份購買首鋼集團有限公司所持北京首鋼鋼貿投資管理有限公司49%股權並募集配套資金的批覆》(首發〔2021〕215號),同意公司發行股份購買首鋼集團所持北京首鋼鋼貿投資管理有限公司49%股權並募集配套資金項目及方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.